Biogen completes Nightstar acquisition by Anna Smith | Jun 7, 2019 | News | 0 The companies announced the acquisition in March this year, with the value estimated at approximately $800 million. Read More
Gyroscope and Orbital to create retinal gene therapy company by Anna Smith | Apr 11, 2019 | News | 0 The two units belong to Sycona, who will own 82% of the company. Read More